Lymphatic endothelial cells - key players in regulation of tolerance and immunity
The lymphatic vasculature provides routes for dendritic cell and lymphocyte migration into and out of lymph nodes. Lymphatic endothelial cells (LEC) control these processes by expression of CCL21, sphingosine-1-phosphate, and adhesion molecules. LEC express MHC-I and MHC-II, but not costimulatory mo...
Saved in:
| Published in | Frontiers in immunology Vol. 3; p. 305 |
|---|---|
| Main Authors | , , , |
| Format | Journal Article |
| Language | English |
| Published |
Switzerland
Frontiers Research Foundation
01.01.2012
Frontiers Media S.A |
| Subjects | |
| Online Access | Get full text |
| ISSN | 1664-3224 1664-3224 |
| DOI | 10.3389/fimmu.2012.00305 |
Cover
| Abstract | The lymphatic vasculature provides routes for dendritic cell and lymphocyte migration into and out of lymph nodes. Lymphatic endothelial cells (LEC) control these processes by expression of CCL21, sphingosine-1-phosphate, and adhesion molecules. LEC express MHC-I and MHC-II, but not costimulatory molecules, and present antigen on MHC-I via both direct and cross-presentation. Whether LEC present to CD4 T cells on MHC-II is unknown. Interestingly, LEC express antigens otherwise restricted to a small number of peripheral tissues in an autoimmune regulatory element-independent manner. Direct presentation of peripheral tissue antigens (PTA) to CD8 T cells results in abortive proliferation and deletion, due to both a lack of costimulation and active PD-L1 engagement. Autoimmunity develops when deletion is subverted, suggesting that LEC presentation of PTA could lead to human disease if PD-1 signaling were impaired by genetic polymorphisms, or aberrant costimulation occurred during inflammation. The expression of additional inhibitory molecules, which are not involved in LEC-mediated deletion, suggests that LEC may have additional immunoregulatory roles. LEC express receptors for several immunomodulatory molecules whose engagement alters their phenotype and function. In this review we describe the role of LEC in distinct anatomical locations in controlling immune cell trafficking, as well as their emerging role in the regulation of T cell tolerance and immunity. |
|---|---|
| AbstractList | The lymphatic vasculature provides routes for dendritic cell and lymphocyte migration into and out of lymph nodes. Lymphatic endothelial cells (LEC) control these processes by expression of CCL21, sphingosine-1-phosphate, and adhesion molecules. LEC express MHC-I and MHC-II, but not costimulatory molecules, and present antigen on MHC-I via both direct and cross-presentation. Whether LEC present to CD4 T cells on MHC-II is unknown. Interestingly, LEC express antigens otherwise restricted to a small number of peripheral tissues in an autoimmune regulatory element-independent manner. Direct presentation of peripheral tissue antigens (PTA) to CD8 T cells results in abortive proliferation and deletion, due to both a lack of costimulation and active PD-L1 engagement. Autoimmunity develops when deletion is subverted, suggesting that LEC presentation of PTA could lead to human disease if PD-1 signaling were impaired by genetic polymorphisms, or aberrant costimulation occurred during inflammation. The expression of additional inhibitory molecules, which are not involved in LEC-mediated deletion, suggests that LEC may have additional immunoregulatory roles. LEC express receptors for several immunomodulatory molecules whose engagement alters their phenotype and function. In this review we describe the role of LEC in distinct anatomical locations in controlling immune cell trafficking, as well as their emerging role in the regulation of T cell tolerance and immunity. The lymphatic vasculature provides routes for dendritic cell and lymphocyte migration into and out of lymph nodes. Lymphatic endothelial cells (LEC) control these processes by expression of CCL21, sphingosine-1-phosphate and adhesion molecules. LEC express MHC-I and MHC-II, but not costimulatory molecules, and present antigen on MHC-I via both direct and cross presentation. Whether LEC present to CD4 T cells on MHC-II is unknown. Interestingly, LEC express antigens otherwise restricted to a small number of peripheral tissues in an Aire independent manner. Direct presentation of peripheral tissue antigens (PTA) to CD8 T cells results in abortive proliferation and deletion, due to both a lack of costimulation and active PD-L1 engagement. Autoimmunity develops when deletion is subverted, suggesting that LEC presentation of PTA could lead to human disease if PD-1 signaling were impaired by genetic polymorphisms, or aberrant costimulation occurred during inflammation. The expression of additional inhibitory molecules, which are not involved in LEC-mediated deletion, suggests that LEC may have additional immunoregulatory roles. LEC express receptors for several immunomodulatory molecules whose engagement alters their phenotype and function. In this review we describe the role of LEC in distinct anatomical locations in controlling immune cell trafficking, as well as their emerging role in the regulation of T cell tolerance and immunity. The lymphatic vasculature provides routes for dendritic cell and lymphocyte migration into and out of lymph nodes. Lymphatic endothelial cells (LEC) control these processes by expression of CCL21, sphingosine-1-phosphate, and adhesion molecules. LEC express MHC-I and MHC-II, but not costimulatory molecules, and present antigen on MHC-I via both direct and cross-presentation. Whether LEC present to CD4 T cells on MHC-II is unknown. Interestingly, LEC express antigens otherwise restricted to a small number of peripheral tissues in an autoimmune regulatory element-independent manner. Direct presentation of peripheral tissue antigens (PTA) to CD8 T cells results in abortive proliferation and deletion, due to both a lack of costimulation and active PD-L1 engagement. Autoimmunity develops when deletion is subverted, suggesting that LEC presentation of PTA could lead to human disease if PD-1 signaling were impaired by genetic polymorphisms, or aberrant costimulation occurred during inflammation. The expression of additional inhibitory molecules, which are not involved in LEC-mediated deletion, suggests that LEC may have additional immunoregulatory roles. LEC express receptors for several immunomodulatory molecules whose engagement alters their phenotype and function. In this review we describe the role of LEC in distinct anatomical locations in controlling immune cell trafficking, as well as their emerging role in the regulation of T cell tolerance and immunity.The lymphatic vasculature provides routes for dendritic cell and lymphocyte migration into and out of lymph nodes. Lymphatic endothelial cells (LEC) control these processes by expression of CCL21, sphingosine-1-phosphate, and adhesion molecules. LEC express MHC-I and MHC-II, but not costimulatory molecules, and present antigen on MHC-I via both direct and cross-presentation. Whether LEC present to CD4 T cells on MHC-II is unknown. Interestingly, LEC express antigens otherwise restricted to a small number of peripheral tissues in an autoimmune regulatory element-independent manner. Direct presentation of peripheral tissue antigens (PTA) to CD8 T cells results in abortive proliferation and deletion, due to both a lack of costimulation and active PD-L1 engagement. Autoimmunity develops when deletion is subverted, suggesting that LEC presentation of PTA could lead to human disease if PD-1 signaling were impaired by genetic polymorphisms, or aberrant costimulation occurred during inflammation. The expression of additional inhibitory molecules, which are not involved in LEC-mediated deletion, suggests that LEC may have additional immunoregulatory roles. LEC express receptors for several immunomodulatory molecules whose engagement alters their phenotype and function. In this review we describe the role of LEC in distinct anatomical locations in controlling immune cell trafficking, as well as their emerging role in the regulation of T cell tolerance and immunity. |
| Author | Cohen, Jarish N. Engelhard, Victor H. Tewalt, Eric F. Rouhani, Sherin J. |
| AuthorAffiliation | 2 Carter Immunology Center, University of Virginia School of Medicine Charlottesville, VA, USA 1 Department of Microbiology, Immunology, and Cancer Biology, University of Virginia School of Medicine Charlottesville, VA, USA |
| AuthorAffiliation_xml | – name: 2 Carter Immunology Center, University of Virginia School of Medicine Charlottesville, VA, USA – name: 1 Department of Microbiology, Immunology, and Cancer Biology, University of Virginia School of Medicine Charlottesville, VA, USA |
| Author_xml | – sequence: 1 givenname: Eric F. surname: Tewalt fullname: Tewalt, Eric F. – sequence: 2 givenname: Jarish N. surname: Cohen fullname: Cohen, Jarish N. – sequence: 3 givenname: Sherin J. surname: Rouhani fullname: Rouhani, Sherin J. – sequence: 4 givenname: Victor H. surname: Engelhard fullname: Engelhard, Victor H. |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/23060883$$D View this record in MEDLINE/PubMed |
| BookMark | eNp1UU1rFDEYDlKxtfbuSXL0Mmu-N3MRpPhRWBBBz-FtktlNzSRrMivMvzezW0sr-F4SkucreV6is5STR-g1JSvOdf9uCON4WDFC2YoQTuQzdEGVEh1nTJw92p-jq1rvSBvRc87lC3TOOFFEa36Bvm3mcb-DKVjsk8vTzscAEVsfY8Ud_ulnvI8w-1JxSLj47SE2cE44D3jK0RdI1mNIDi9pUpjmV-j5ALH6q_v1Ev349PH79Zdu8_XzzfWHTWcl01OnmRacWA1cMknXksBghQQ_KNk74nrGlaLSEcmAUAtSrIG6tbOaDmLNBeeX6Oak6zLcmX0JI5TZZAjmeJDL1kBp74reeAuDpsQCJ1r0Qt365ucUB8Wcb2ma1vuT1v5wO3pnfZoKxCeiT29S2Jlt_m24UITJvgm8vRco-dfB18mMoS6fCMnnQzW0jZZ9LxevN4-9Hkz-dtIA5ASwJdda_PAAocQszZtj82Zp3hybbxT1D8WG6dhTSxvi_4l_AAySs2U |
| CitedBy_id | crossref_primary_10_1186_s41232_021_00175_6 crossref_primary_10_1089_adt_2016_764 crossref_primary_10_1186_s12929_022_00868_1 crossref_primary_10_1080_2162402X_2016_1204505 crossref_primary_10_3389_fimmu_2019_00471 crossref_primary_10_1172_JCI71607 crossref_primary_10_1038_s41569_018_0087_8 crossref_primary_10_1016_j_autrev_2017_07_008 crossref_primary_10_1016_j_imlet_2016_06_002 crossref_primary_10_3390_ijms18010051 crossref_primary_10_1161_CIRCULATIONAHA_123_064181 crossref_primary_10_1186_s12915_017_0471_6 crossref_primary_10_1016_j_coviro_2014_06_006 crossref_primary_10_1182_bloodadvances_2020001468 crossref_primary_10_1371_journal_pone_0156079 crossref_primary_10_1038_nrc3677 crossref_primary_10_1016_j_biomaterials_2015_11_027 crossref_primary_10_3389_fimmu_2019_01033 crossref_primary_10_3389_fimmu_2017_01907 crossref_primary_10_1016_j_jss_2015_02_031 crossref_primary_10_1002_iid3_32 crossref_primary_10_1172_JCI71606 crossref_primary_10_3389_fimmu_2023_1206504 crossref_primary_10_3390_biomedicines11123234 crossref_primary_10_3390_ijms21249492 crossref_primary_10_1186_s12967_021_02922_2 crossref_primary_10_1063_1_5133970 crossref_primary_10_1038_s41590_022_01158_6 crossref_primary_10_4049_jimmunol_1103621 crossref_primary_10_3390_ijms232113470 crossref_primary_10_1111_bjh_16377 crossref_primary_10_3389_fimmu_2015_00446 crossref_primary_10_3390_cells10061371 crossref_primary_10_1172_JCI83379 crossref_primary_10_1002_eji_201545739 crossref_primary_10_3389_fmicb_2014_00733 crossref_primary_10_1002_eji_201948103 crossref_primary_10_1016_j_mvr_2014_07_004 crossref_primary_10_3389_fimmu_2015_00603 crossref_primary_10_1097_PRS_0000000000009997 crossref_primary_10_3389_fimmu_2017_00104 crossref_primary_10_1038_srep45263 crossref_primary_10_1002_msp2_29 crossref_primary_10_1016_j_semcdb_2014_11_012 crossref_primary_10_3390_cancers12082280 crossref_primary_10_1111_acel_70000 crossref_primary_10_1371_journal_pone_0132661 crossref_primary_10_1111_aji_12970 crossref_primary_10_1002_ctm2_70086 crossref_primary_10_1007_s10456_013_9404_3 crossref_primary_10_1007_s10456_013_9406_1 crossref_primary_10_3390_cancers14071823 crossref_primary_10_1016_j_hlc_2022_02_012 crossref_primary_10_1074_jbc_M115_708305 crossref_primary_10_1016_j_jshs_2022_12_011 crossref_primary_10_1038_s41467_025_55969_w crossref_primary_10_3390_ijms222111976 crossref_primary_10_1007_s00018_021_03873_z crossref_primary_10_1016_j_bbcan_2025_189278 |
| ContentType | Journal Article |
| Copyright | Copyright © Tewalt, Cohen, Rouhani and Engelhard. 2012 |
| Copyright_xml | – notice: Copyright © Tewalt, Cohen, Rouhani and Engelhard. 2012 |
| DBID | AAYXX CITATION NPM 7X8 5PM DOA |
| DOI | 10.3389/fimmu.2012.00305 |
| DatabaseName | CrossRef PubMed MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic PubMed |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Biology |
| EISSN | 1664-3224 |
| ExternalDocumentID | oai_doaj_org_article_ecaf810ca3084946be750d63a62de528 PMC3460259 23060883 10_3389_fimmu_2012_00305 |
| Genre | Journal Article |
| GrantInformation_xml | – fundername: NCI NIH HHS grantid: P30 CA044579 – fundername: NIGMS NIH HHS grantid: T32 GM007267 – fundername: NHLBI NIH HHS grantid: T32 HL007284 – fundername: NIAID NIH HHS grantid: R01 AI068836 – fundername: NIAID NIH HHS grantid: T32 AI007496 |
| GroupedDBID | 53G 5VS 9T4 AAFWJ AAKDD AAYXX ACGFO ACGFS ACXDI ADBBV ADRAZ AENEX AFPKN ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BCNDV CITATION DIK EBS EMOBN GROUPED_DOAJ GX1 HYE IPNFZ KQ8 M48 M~E OK1 PGMZT RIG RNS RPM NPM 7X8 5PM |
| ID | FETCH-LOGICAL-c528t-828430c8a35251750afc45aef659d0d9236615d052a01ca547a1d7dc81f473433 |
| IEDL.DBID | M48 |
| ISSN | 1664-3224 |
| IngestDate | Wed Aug 27 01:31:53 EDT 2025 Thu Aug 21 13:22:45 EDT 2025 Fri Sep 05 05:02:00 EDT 2025 Thu Apr 03 07:09:44 EDT 2025 Thu Apr 24 22:56:32 EDT 2025 Tue Jul 01 01:57:06 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Keywords | lymphatic endothelial cells antigen presentation inflammation trafficking tolerance |
| Language | English |
| License | This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in other forums, provided the original authors and source are credited and subject to any copyright notices concerning any third-party graphics etc. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c528t-828430c8a35251750afc45aef659d0d9236615d052a01ca547a1d7dc81f473433 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Edited by: Christopher G. Mueller, Centre National de la Recherche Scientifique, France This article was submitted to Frontiers in Antigen Presenting Cell Biology, a specialty of Frontiers in Immunology Reviewed by: Melody A. Swartz, Ecole Polytechnique Fédérale de Lausanne, Switzerland; Theresa T. Lu, Hospital for Special Surgery/Weill Cornell Medical Center, USA; Christopher G. Mueller, Centre National de la Recherche Scientifique, France Eric F. Tewalt, Jarish N. Cohen, and Sherin J. Rouhani have contributed equally to this work. |
| OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.3389/fimmu.2012.00305 |
| PMID | 23060883 |
| PQID | 1111859958 |
| PQPubID | 23479 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_ecaf810ca3084946be750d63a62de528 pubmedcentral_primary_oai_pubmedcentral_nih_gov_3460259 proquest_miscellaneous_1111859958 pubmed_primary_23060883 crossref_primary_10_3389_fimmu_2012_00305 crossref_citationtrail_10_3389_fimmu_2012_00305 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2012-01-01 |
| PublicationDateYYYYMMDD | 2012-01-01 |
| PublicationDate_xml | – month: 01 year: 2012 text: 2012-01-01 day: 01 |
| PublicationDecade | 2010 |
| PublicationPlace | Switzerland |
| PublicationPlace_xml | – name: Switzerland |
| PublicationTitle | Frontiers in immunology |
| PublicationTitleAlternate | Front Immunol |
| PublicationYear | 2012 |
| Publisher | Frontiers Research Foundation Frontiers Media S.A |
| Publisher_xml | – name: Frontiers Research Foundation – name: Frontiers Media S.A |
| References | 15534368 - J Exp Med. 2004 Nov 15;200(10):1231-41 1269772 - Fed Proc. 1976 Jun;35(8):1863-71 15485628 - Immunity. 2004 Oct;21(4):503-13 22149932 - Annu Rev Immunol. 2012;30:69-94 11857337 - Eur J Immunol. 2002 Mar;32(3):634-43 19587009 - J Immunol. 2009 Aug 1;183(3):1767-79 21059923 - Proc Natl Acad Sci U S A. 2010 Nov 23;107(47):20447-52 17938282 - J Histochem Cytochem. 2008 Feb;56(2):97-109 11070085 - Proc Natl Acad Sci U S A. 2000 Nov 7;97(23):12694-9 20921966 - Immunol Cell Biol. 2011 Mar;89(3):475-81 22430738 - J Immunol. 2012 Apr 15;188(8):4065-80 22832193 - Cell Rep. 2012 Mar 29;1(3):191-9 12163561 - J Exp Med. 2002 Aug 5;196(3):323-33 15699134 - J Immunol. 2005 Feb 15;174(4):2046-53 17195844 - Nat Immunol. 2007 Feb;8(2):181-90 17142723 - J Immunol. 2006 Dec 15;177(12):8291-5 1313950 - Nature. 1992 Apr 16;356(6370):607-9 19060900 - Nat Immunol. 2009 Jan;10(1):58-65 20308362 - J Exp Med. 2010 Apr 12;207(4):689-97 20308365 - J Exp Med. 2010 Apr 12;207(4):681-8 19342624 - J Immunol. 2009 Apr 15;182(8):4516-20 16473832 - Immunity. 2006 Feb;24(2):203-15 22884313 - Immunity. 2012 Aug 24;37(2):276-89 17116732 - J Exp Med. 2006 Nov 27;203(12):2763-77 21841786 - Nat Immunol. 2011 Sep;12(9):879-87 22459150 - FASEB J. 2012 Jul;26(7):2835-46 22993390 - Blood. 2012 Dec 6;120(24):4772-82 2217560 - Physiol Rev. 1990 Oct;70(4):987-1028 17289811 - Blood. 2007 Jul 1;110(1):180-5 19454662 - J Immunol. 2009 Jun 1;182(11):6682-9 18687966 - Science. 2008 Aug 8;321(5890):843-7 21256057 - Immunity. 2011 Jan 28;34(1):96-107 21930767 - J Exp Med. 2011 Sep 26;208(10):2141-53 18451854 - Nature. 2008 May 1;453(7191):51-5 15297319 - Blood. 2004 Dec 15;104(13):3849-57 19668219 - Nat Immunol. 2009 Sep;10(9):1026-33 19762711 - Am J Pathol. 2009 Oct;175(4):1733-45 19564355 - J Exp Med. 2009 Jul 6;206(7):1505-13 17617591 - J Immunol. 2007 Jul 15;179(2):993-1003 21926986 - Nat Immunol. 2011 Nov;12(11):1096-104 19201863 - J Immunol. 2009 Feb 15;182(4):2102-12 18292566 - J Immunol. 2008 Mar 1;180(5):3399-405 10523616 - J Exp Med. 1999 Oct 18;190(8):1183-8 22110583 - PLoS One. 2011;6(11):e26138 16724117 - EMBO J. 2006 Jun 7;25(11):2623-33 17360402 - Proc Natl Acad Sci U S A. 2007 Mar 20;104(12):5026-31 20937843 - J Immunol. 2010 Nov 15;185(10):5769-77 22566840 - Front Immunol. 2011;2:50 16056255 - Nat Rev Immunol. 2005 Aug;5(8):617-28 19346498 - Blood. 2009 May 28;113(22):5650-9 17289814 - Blood. 2007 Jun 1;109(11):4777-85 11123313 - J Immunol. 2001 Jan 1;166(1):361-9 19901262 - Blood. 2010 Jan 14;115(2):418-29 17932562 - J Clin Invest. 2007 Nov;117(11):3383-92 20471289 - Immunity. 2010 May 28;32(5):703-13 17893676 - Nat Immunol. 2007 Nov;8(11):1255-65 18523807 - Cell Tissue Res. 2008 Aug;333(2):237-52 19017956 - J Immunol. 2008 Dec 1;181(11):7681-8 12376594 - Science. 2002 Nov 15;298(5597):1395-401 19995949 - J Exp Med. 2009 Dec 21;206(13):2925-35 17392506 - Blood. 2007 Jul 1;110(1):186-92 21123547 - J Gen Virol. 2011 Mar;92(Pt 3):650-60 20566898 - Blood. 2010 Sep 23;116(12):2173-82 11602634 - J Exp Med. 2001 Oct 15;194(8):1033-42 11560993 - J Exp Med. 2001 Sep 17;194(6):769-79 18926287 - Immunobiology. 2008;213(9-10):715-28 18164221 - Immunity. 2008 Jan;28(1):122-33 17823289 - Am J Pathol. 2007 Oct;171(4):1249-57 |
| References_xml | – reference: 18687966 - Science. 2008 Aug 8;321(5890):843-7 – reference: 22110583 - PLoS One. 2011;6(11):e26138 – reference: 17360402 - Proc Natl Acad Sci U S A. 2007 Mar 20;104(12):5026-31 – reference: 17938282 - J Histochem Cytochem. 2008 Feb;56(2):97-109 – reference: 19901262 - Blood. 2010 Jan 14;115(2):418-29 – reference: 19995949 - J Exp Med. 2009 Dec 21;206(13):2925-35 – reference: 20471289 - Immunity. 2010 May 28;32(5):703-13 – reference: 19346498 - Blood. 2009 May 28;113(22):5650-9 – reference: 17195844 - Nat Immunol. 2007 Feb;8(2):181-90 – reference: 19454662 - J Immunol. 2009 Jun 1;182(11):6682-9 – reference: 17932562 - J Clin Invest. 2007 Nov;117(11):3383-92 – reference: 19017956 - J Immunol. 2008 Dec 1;181(11):7681-8 – reference: 19564355 - J Exp Med. 2009 Jul 6;206(7):1505-13 – reference: 21841786 - Nat Immunol. 2011 Sep;12(9):879-87 – reference: 21123547 - J Gen Virol. 2011 Mar;92(Pt 3):650-60 – reference: 11560993 - J Exp Med. 2001 Sep 17;194(6):769-79 – reference: 11070085 - Proc Natl Acad Sci U S A. 2000 Nov 7;97(23):12694-9 – reference: 1313950 - Nature. 1992 Apr 16;356(6370):607-9 – reference: 11602634 - J Exp Med. 2001 Oct 15;194(8):1033-42 – reference: 17893676 - Nat Immunol. 2007 Nov;8(11):1255-65 – reference: 21059923 - Proc Natl Acad Sci U S A. 2010 Nov 23;107(47):20447-52 – reference: 15534368 - J Exp Med. 2004 Nov 15;200(10):1231-41 – reference: 17289814 - Blood. 2007 Jun 1;109(11):4777-85 – reference: 20921966 - Immunol Cell Biol. 2011 Mar;89(3):475-81 – reference: 22459150 - FASEB J. 2012 Jul;26(7):2835-46 – reference: 19060900 - Nat Immunol. 2009 Jan;10(1):58-65 – reference: 18292566 - J Immunol. 2008 Mar 1;180(5):3399-405 – reference: 17142723 - J Immunol. 2006 Dec 15;177(12):8291-5 – reference: 20937843 - J Immunol. 2010 Nov 15;185(10):5769-77 – reference: 16056255 - Nat Rev Immunol. 2005 Aug;5(8):617-28 – reference: 18451854 - Nature. 2008 May 1;453(7191):51-5 – reference: 19342624 - J Immunol. 2009 Apr 15;182(8):4516-20 – reference: 17823289 - Am J Pathol. 2007 Oct;171(4):1249-57 – reference: 12163561 - J Exp Med. 2002 Aug 5;196(3):323-33 – reference: 22566840 - Front Immunol. 2011;2:50 – reference: 16724117 - EMBO J. 2006 Jun 7;25(11):2623-33 – reference: 17289811 - Blood. 2007 Jul 1;110(1):180-5 – reference: 20308365 - J Exp Med. 2010 Apr 12;207(4):681-8 – reference: 22993390 - Blood. 2012 Dec 6;120(24):4772-82 – reference: 2217560 - Physiol Rev. 1990 Oct;70(4):987-1028 – reference: 21930767 - J Exp Med. 2011 Sep 26;208(10):2141-53 – reference: 17617591 - J Immunol. 2007 Jul 15;179(2):993-1003 – reference: 17116732 - J Exp Med. 2006 Nov 27;203(12):2763-77 – reference: 18164221 - Immunity. 2008 Jan;28(1):122-33 – reference: 12376594 - Science. 2002 Nov 15;298(5597):1395-401 – reference: 17392506 - Blood. 2007 Jul 1;110(1):186-92 – reference: 20308362 - J Exp Med. 2010 Apr 12;207(4):689-97 – reference: 21926986 - Nat Immunol. 2011 Nov;12(11):1096-104 – reference: 18926287 - Immunobiology. 2008;213(9-10):715-28 – reference: 22884313 - Immunity. 2012 Aug 24;37(2):276-89 – reference: 18523807 - Cell Tissue Res. 2008 Aug;333(2):237-52 – reference: 15485628 - Immunity. 2004 Oct;21(4):503-13 – reference: 11123313 - J Immunol. 2001 Jan 1;166(1):361-9 – reference: 21256057 - Immunity. 2011 Jan 28;34(1):96-107 – reference: 20566898 - Blood. 2010 Sep 23;116(12):2173-82 – reference: 15297319 - Blood. 2004 Dec 15;104(13):3849-57 – reference: 22430738 - J Immunol. 2012 Apr 15;188(8):4065-80 – reference: 11857337 - Eur J Immunol. 2002 Mar;32(3):634-43 – reference: 15699134 - J Immunol. 2005 Feb 15;174(4):2046-53 – reference: 19668219 - Nat Immunol. 2009 Sep;10(9):1026-33 – reference: 19587009 - J Immunol. 2009 Aug 1;183(3):1767-79 – reference: 19201863 - J Immunol. 2009 Feb 15;182(4):2102-12 – reference: 19762711 - Am J Pathol. 2009 Oct;175(4):1733-45 – reference: 22149932 - Annu Rev Immunol. 2012;30:69-94 – reference: 1269772 - Fed Proc. 1976 Jun;35(8):1863-71 – reference: 22832193 - Cell Rep. 2012 Mar 29;1(3):191-9 – reference: 10523616 - J Exp Med. 1999 Oct 18;190(8):1183-8 – reference: 16473832 - Immunity. 2006 Feb;24(2):203-15 |
| SSID | ssj0000493335 |
| Score | 2.231012 |
| Snippet | The lymphatic vasculature provides routes for dendritic cell and lymphocyte migration into and out of lymph nodes. Lymphatic endothelial cells (LEC) control... |
| SourceID | doaj pubmedcentral proquest pubmed crossref |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
| StartPage | 305 |
| SubjectTerms | Antigen Presentation Immunology Lymph Node lymph node stromal cells lymphatic endothelial cells lymphatics tolerance mechanisms |
| SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3BbtQwELVQJSQuFS3QboHKSFw4ROvEdmIfAbGqEHCBSnuLJrYjttpNqjZ72Bv_0D_kSzpj7652UQUXrrGTWG_G8RvH84axtyClq3zls8rkkCnrfWZaKLLWNDkYUVoZdQq-fisvLtXnqZ7ulPqiM2FJHjgBNw4OWpMLB1IYZVXZBFzjfCmhLHzQRUzzFVbsBFNXifdKKXX6L4lRmB23s8ViSUe5SKBTUrW6nXUoyvU_xDH_PCq5s_ZMnrLDNWnk79Ngj9ij0B2zx6mM5OoZ-_5lhTYh6VUeOk8pVXP0Kk578rf89687jhOVX8-B2DWfdfwm1Z9Hi_C-5UM_D1RdI3DoPJ_FfJFh9ZxdTj79-HiRrYslZA5RGCgdXEnhDJC-KXICAa1TGkJbauuFRx6HK7H2QhcgcgdaVZCjjZzJW1VJJeULdtD1XThl3GvlgWRpKmzQJjQKH2pFY4PCYKcqRmy8ga52ayVxKmgxrzGiILDrCHZNYNcR7BF7t73jOqlo_KXvB7LGth_pX8cL6BX12ivqf3nFiL3Z2LLG-UKAQxf65W2MeAyprGGfk2Tb7asoHMOvrhyxas_qe2PZb-lmP6Mmt1Qlskd79j8G_5I9ITjSRs8rdjDcLMNrpD5Dcx69_B64xQJw priority: 102 providerName: Directory of Open Access Journals |
| Title | Lymphatic endothelial cells - key players in regulation of tolerance and immunity |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/23060883 https://www.proquest.com/docview/1111859958 https://pubmed.ncbi.nlm.nih.gov/PMC3460259 https://doaj.org/article/ecaf810ca3084946be750d63a62de528 |
| Volume | 3 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELaqokpcELQ8FtrKSFw4hDqxnTiHCtGqpaoACYmV9hZNbIcuSpOym5XYf8-Mk13YauGSQ_xIPOORv7E93zD2BqS0mctclJkYIpU7F5kKkqgyZQxGpLkMPAWfv6RXY3U90ZM_4dGDAOdbXTvKJzWe1e9-_Vy-R4M_JY8T19uTanp7u6BbWsS9KYnQ9EE4LaKLfAPY_9FjYSml7s8qtzYkZmCE0Gh4cmOZCmz-2yDo_ZuUfy1Nl4_ZowFT8g_9JHjCdnyzz_b6LJPLA_b10xJVRsys3DeOIq5qnHSctuznPOJoxfyuBoLefNrwWZ-cHtXF24p3be0p9Ybn0Dg-DcEk3fIpG19efDu_ioZMCpHViekoVlxJYQ0Q-SkCBgGVVRp8lercCYcgD5dp7YROQMQWtMogRgVaE1cqk0rKZ2y3aRv_gnGnlQPirMmwQBtfKuw0F2XuFXpCWTJiJyvBFXagGadsF3WB7gZJvQhSL0jqRZD6iL1dt7jrKTb-U_eMdLGuR-TY4UU7-14MtlZ4C5WJhQUpjMpVWnocsUslpInzKI8Re73SZIHGROKGxreLeXCHDFGwYZ3nvWbXn1rNjBHLNnS-8S-bJc30JhB2S5UitMxf_rPPV-whjbHf2jlku91s4Y8Q7HTlcdgkwOfHSXwc5vNvWGT9VQ |
| linkProvider | Scholars Portal |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Lymphatic+endothelial+cells+-+key+players+in+regulation+of+tolerance+and+immunity&rft.jtitle=Frontiers+in+immunology&rft.au=Tewalt%2C+Eric+F&rft.au=Cohen%2C+Jarish+N&rft.au=Rouhani%2C+Sherin+J&rft.au=Engelhard%2C+Victor+H&rft.date=2012-01-01&rft.eissn=1664-3224&rft.volume=3&rft.spage=305&rft_id=info:doi/10.3389%2Ffimmu.2012.00305&rft_id=info%3Apmid%2F23060883&rft.externalDocID=23060883 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1664-3224&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1664-3224&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1664-3224&client=summon |